Supriya Lifescience has announced the appointment of Rajeev Kumar Jain as Chief Executive Officer (CEO) & Key Managerial Personnel (KMP) w.e.f. October 3, 2022. Jain is a Master of Business Administration (Marketing) from Jivaji University, Gwalior and BSc (PCB) with distinction. Additionally, he has taken part in business seminars and workshops on corporate transformation in China, Germany, and the Netherlands.

He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API with a 'Safety First, Quality Must and EBIDTA Growth' mindset.

Throughout his career, he has maintained an impeccable record with reputable companies like Morepen Labs Ltd., Ind Swift Labs, Arch Pharma, Trident Group, Max India (DSM), etc. He has strategic leadership attributes with a global mindset and has demonstrated lead for cross-functional teams with end-to-end solutions & managing optimal utilization of Men, Machine & Material.